CRY1 rs8192440: Circadian Biology and Trait Associations
The genetic variant rs8192440 is a synonymous single nucleotide polymorphism situated in the human cryptochrome circadian regulator 1 (CRY1) gene. CRY1 produces a key transcriptional repressor that helps govern the body's intrinsic 24-hour biological clock and cellular rhythmicity. Scientific interest in rs8192440 stems from observational research exploring neurological traits and diurnal patterns, though its clinical significance remains non-pathogenic and distinct from rare high-impact sleep disorders.
What each genotype means
Increased cluster headache susceptibility
Research indicates that the G allele of this variant is associated with an increased susceptibility to cluster headaches, particularly in individuals whose attacks follow a diurnal rhythm. This variant is synonymous, meaning it does not change the amino acid sequence of the CRY1 protein, though it may influence gene expression or mRNA stability. Please discuss any concerns regarding headache patterns or sleep-related symptoms with your healthcare provider.
This is the major genotype observed in many populations, though specific frequency data varies by ancestry.
Typical circadian rhythm profile
This genotype represents a heterozygous state for the rs8192440 variant. While the G allele has been linked to cluster headache susceptibility in some studies, the presence of the A allele may modulate this effect. As this is a common genetic variation, it is not considered a diagnostic marker for any specific condition, and you should consult your physician for personalized medical advice.
This heterozygous genotype is commonly found in the general population.
Baseline risk profile
This genotype represents the homozygous minor allele state for this variant. Current research suggests that the A allele is less strongly associated with the cluster headache susceptibility observed in studies of the G allele. This finding should be interpreted as a general observation from population-level research rather than a specific medical prediction for your health.
This genotype is less common than the GG or GA genotypes in many European populations.
Variant Classification and Molecular Context
Identified systematically as rs8192440, this variation is located within the coding sequence of the CRY1 gene on chromosome 12. Specifically, it represents a silent substitution (c.636T>C or c.636G>A depending on strand orientation, encoding p.Gly212=), meaning that despite the single base transition, the resulting amino acid in the encoded CRY1 peptide chain remains unchanged. Because it does not alter the underlying primary protein sequence, computational algorithms and functional assays generally categorize it as a benign or synonymous baseline polymorphism. While certain synonymous variants can occasionally influence mRNA folding dynamics, splicing efficiency, or ribosomal translation pacing, molecular examinations of rs8192440 have demonstrated minimal to no baseline shift in CRY1 RNA expression or biological stability.
The Biological Role of the CRY1 Gene
The CRY1 gene encodes the cryptochrome circadian regulator 1 protein, an evolutionarily conserved flavoprotein homologous to photolyases that acts as an indispensable component of the negative limb of the human circadian feedback loop. Together with PERIOD proteins (PER1, PER2, and PER3), CRY1 forms molecular complexes that translocate to the nucleus to repress the transcriptional activity orchestrated by the CLOCK and BMAL1 heterodimer. This cyclical feedback mechanism generates the molecular oscillations responsible for coordinating core body temperature, hormone secretion such as nighttime melatonin release, metabolic cycles, and behavioral sleep-wake patterns across a standard 24-hour cycle. Disruptions or mutations that enhance or diminish CRY1 activity can directly lengthen or shorten these internal timing cycles.
Scientific Evidence and Neurological Associations
Research evaluating rs8192440 has primarily surfaced through candidate gene association studies examining circadian rhythm traits and neurological phenotypes. Notably, a Swedish case-control study screened clock-related genetic loci in cluster headache cohorts, discovering modest statistical differences in rs8192440 allele distributions, particularly in individuals whose headache attacks exhibited pronounced diurnal or seasonal rhythmicity. However, direct in vitro testing of primary cells stratified by rs8192440 genotypes did not reveal significant differences in CRY1 gene expression, suggesting the variant may merely be in linkage disequilibrium with other untyped functional markers rather than driving pathology itself. Broader genome-wide association studies (GWAS) have not established strong independent or diagnostic effect sizes for this marker, categorizing the current evidentiary strength as limited.
Distinction from Familial Sleep Phase Mutations
It is critical for individuals reviewing genomic data to distinguish rs8192440 from the rare, high-penetrance CRY1 splice variant historically dubbed the 'night owl' gene. Landmark circadian research published in the journal Cell characterized a distinct dominant splice-site variant (c.1657+3A>C) that induces the skipping of exon 11, resulting in an overactive transcriptional inhibitor that significantly lengthens human circadian period and causes familial Delayed Sleep Phase Disorder (DSPD). When researchers fully sequenced individuals harboring that causal DSPD allele, the silent variant rs8192440 was incidentally noted on the same transcripts as a non-pathogenic background variant present across both affected and general populations. As such, possessing an allele at rs8192440 does not equate to carrying the exon-skipping familial sleep phase mutation.
Navigating Results and Actionable Boundaries
Identifying your rs8192440 genotype provides academic insight into standard circadian gene variation, but it does not serve as a clinical diagnostic tool or medical predictor. Because this variant carries neutral functional impact and limited, non-causal associations, it cannot diagnose sleep disorders, predict the onset of headache conditions, or dictate pharmaceutical responsiveness. Individuals experiencing severe disruptions in sleep timing, chronic daytime fatigue, or debilitating headaches should avoid attributing these experiences to a single silent genetic marker. Rather, practical sleep hygiene, structured light exposure, and formal evaluations with a sleep specialist or neurologist remain the established clinical pathway for addressing circadian and neurological symptoms.
How common is this variant?
The rs8192440 polymorphism is relatively common across global populations, displaying minor allele frequencies typically between 0.15 and 0.25 depending on global ancestry, while some specific subpopulations report localized minor allele frequencies ranging down to ~0.01.
Frequently asked questions
Does having rs8192440 mean I have delayed sleep phase disorder?
No. The variant rs8192440 is a common synonymous marker and is entirely distinct from the rare CRY1 exon-11 skipping mutation (c.1657+3A>C) that causes inherited delayed sleep phase disorder. Having this variant does not mean you have an inherited circadian rhythm disorder.
Can rs8192440 predict whether I will get cluster headaches?
No, it cannot be used to predict or diagnose cluster headaches. While a single small study detected a modest statistical correlation in patients with diurnal headache cycles, the variant does not alter CRY1 protein function and has not been established as a causal risk factor.
What is a synonymous or silent genetic variant?
A synonymous variant is a DNA change occurring within a protein-coding region that changes the nucleotide sequence without changing the resulting amino acid. Because the amino acid remains the same, the structural blueprint of the produced protein is preserved.
Should I make lifestyle changes based on my rs8192440 genotype?
No specific medical or lifestyle modifications are recommended based on this variant alone. Healthy sleep practices, consistent exposure to daylight, and professional consultation for persistent sleep issues are far more impactful than individual common clock gene polymorphisms.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs8192440?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CRY1
This intronic variant in the CRY1 gene is associated with delayed sleep-wake phase disorder (DSWPD) and has been linked to variations in glycemic parameters and insulin resistance.
This splice donor mutation (c.1657+1G>A) causes exon 11 skipping, leading to an overactive repressor complex and familial delayed sleep phase disorder.
Variant in the CRY1 gene, which encodes a core component of the circadian clock, associated with sleep timing and delayed sleep phase.
Dominant splice-site mutation (c.1657+3A>C) in CRY1, resulting in skipping of exon 11 and associated with delayed sleep-wake phase disorder (DSWPD).
Cryptochrome 1 variant linked to sleep-wake timing variations and subjective poor sleep phenotypes.
This SNP is located in the CRY1 gene, which encodes a core circadian clock protein involved in regulating sleep-wake cycles.